IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

Skip to Main content
  • Cost and Savings
  • Patient Information
  • Healthcare Professional Site
  • Talk To A Doctor
  • $0 Savings Offer
Ubrelvy-logo
  • Ubrelvy-logo
  • home
  • why ubrelvy
  • savings
  • Resources
    • visit resources
    • Find a Specialist
    • UBRELVY Brochure
    • Essential Tips
    • MIGRAINE ORGANIZATIONS
    • Join Our Community
  • treating migraine
    • Treating Migraine
    • FAQS
  • real patient stories
  • U-Save Card
  • Telemedicine
  • Sign Up
  • UBRELVY Pricing
  • Healthcare Professional Site
  • Patient Information
  • Important Safety Information
  • social
    • insta
    • fb
    • tiktok
    • youtube
    • twitter

UBRELVY SITE MAP

  • Home
  • Why UBRELVY
  • Savings
  • Resources
  • Treating Migraine
  • Real Patient Stories
  • Email Signup
  • U-Save Card Signup
  • Telemedicine
  • Healthcare Professional Site
  • Patient Information
  • Important Safety Information
  • Privacy Policy
  • Contact Us

IMPORTANT SAFETY INFORMATION

Who should not take UBRELVY® (ubrogepant)?
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

What should I tell my healthcare provider before taking UBRELVY?
Tell your healthcare provider about all your medical conditions, including if you:

  • Have liver problems
  • Have kidney problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.

What are the most common side effects of UBRELVY?
The most common side effects are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.

What is UBRELVY?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.

US-UBR-220187

Please see full Patient Information.

ubrelvy-footer-logo

Home

Savings

Treating Migraine

Why Ubrelvy

Resources

Real Patient Stories

U-Concierge

For questions, call
1.844.4.UBRELVY (1.844.482.7358),
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.

  • instagram
  • facebook
  • tiktok
  • youtube
  • twitter

Home

Why Ubrelvy

Savings

Resources

Treating Migraine

Real Patient Stories

U-Concierge

For questions, call
1.844.4.UBRELVY (1.844.482.7358),
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.

  • U-Save Card
  • Telemedicine
  • Contact Us
  • Healthcare Professional Site
  • Site Map
  • Privacy Statement
  • Terms of Use
  • Cookies Settings
 

This site is intended for U.S. consumers only. UBRELVY® and its design are registered trademarks of Allergan Pharmaceuticals International Limited, an AbbVie company. © 2022 AbbVie. All rights reserved.

US-UBR-220138

SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU

Use telemedicine to connect to a doctor. Here's how:

  • chat bubbles icon

    Answer a few simple questions about your migraine attacks and current treatment plan.

  • stethoscope inside phone icon

    Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.

  • rx paper icon

    If a prescription is written, you can pick it up at a local pharmacy you choose.

AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0 A MONTH* FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.

*Patient out-of-pocket costs may vary. Terms and Conditions apply. This offer is only valid for commercially insured patients. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Please see full Program Terms, Conditions, and Eligibility Criteria.
†Message and data rates may apply. Reply HELP for help; reply STOP to cancel. Message frequency depends on user. Consent not required to purchase goods/services.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.

By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.

If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.

TALK NOW
BACK TO SITE

THANK YOU FOR SIGNING UP

Due to popular demand, UBRELVY is temporarily unavailable but should be back in pharmacies shortly

PROGRAM TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA:

  1. This offer is valid only for patients 18 years of age or older and is good for use only with a valid prescription for UBRELVY® (ubrogepant) tablets at the time the prescription is filled by the pharmacist and dispensed to the patient.
  2. This offer is not valid for use by patients enrolled in Medicare, Medicaid, or other federal or state programs (including any state pharmaceutical assistance programs) or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. Patients may not use this card if they are Medicare-eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees. If at any time, a participating patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be eligible for the UBRELVY U-Save Savings Program and must cease participation. This offer is not valid for cash-paying patients.
  3. Patient out-of-pocket expense will vary. Depending on insurance coverage, eligible commercially insured patients may pay as little as $0 per monthly prescription fill. Check with your pharmacist for your copay discount. Subject to all other terms and conditions, a commercially insured patient whose plan covers UBRELVY will pay $0 for their first one-month prescription fill of UBRELVY per calendar year, and for subsequent monthly fills, the maximum savings that may be available solely for the patient’s benefit is $50 per pill. This offer is valid for up to 13 prescription fills.
  4. Commercially insured patients whose plans require a prior authorization may be eligible to pay $0 for a maximum of two (2) one-month fills while the prior authorization is pending. Commercially insured patients whose plans do not cover UBRELVY may be eligible to pay $0 for a maximum of four (4) one-month fills where coverage is not available because the insurer has not established a coverage review process. Commercially insured patients whose plans require a prior authorization or do not cover UBRELVY cannot apply savings received from the UBRELVY U-Save Savings Program toward any out- of-pocket limits or other deductibles under their insurance coverage.
  5. Patients may not seek reimbursement for value received from the UBRELVY U-Save Savings Program from any third-party payers.
  6. AbbVie reserves the right to rescind, revoke, or amend this offer without notice.
  7. Offer good only in the USA, including Puerto Rico, at participating retail pharmacies. Patients residing in or receiving treatment in certain states may not be eligible to participate in this program.
  8. Void if prohibited by law, taxed, or restricted.
  9. This card is not transferable. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.
  10. This card has no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription.
  11. This offer is not health insurance.
  12. By redeeming this offer, you acknowledge that you are an eligible commercially insured patient and that you understand and agree to comply with the above terms and conditions.

For questions about the program, including savings on mail-order prescriptions, or to activate your card ID, please call 1-844-577-6239.

To learn about AbbVie’s privacy practices and your privacy choices, visit https://privacy.abbvie.

Program managed by ConnectiveRx on behalf of AbbVie.

US-UBR-220304

SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU

Use telemedicine to connect to a doctor. Here's how:

  • chat bubbles icon

    Answer a few simple questions about your migraine attacks and current treatment plan.

  • stethoscope inside phone icon

    Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.

  • rx paper icon

    If a prescription is written, you can pick it up at a local pharmacy you choose.

AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0 A MONTH* FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.

*Patient out-of-pocket costs may vary. Terms and Conditions apply. This offer is only valid for commercially insured patients. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Please see full Program Terms, Conditions, and Eligibility Criteria.
†Message and data rates may apply. Reply HELP for help; reply STOP to cancel. Message frequency depends on user. Consent not required to purchase goods/services.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.

By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.

If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.

TALK NOW
BACK TO SITE

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

IMPORTANT SAFETY INFORMATION

Who should not take UBRELVY® (ubrogepant)?
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

What should I tell my healthcare provider before taking UBRELVY?
Tell your healthcare provider about all your medical conditions, including if you:

  • Have liver problems
  • Have kidney problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.

What are the most common side effects of UBRELVY?
The most common side effects are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.

What is UBRELVY?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.

US-UBR-220187